Frontier Biotechnologies

OverviewSuggest Edit

Frontier Biotechnologies (前沿生物, 前沿生物药业(南京)股份有限公司) is a biopharmaceutical company. Its product Albuvirtide is used for HIV infection and AIDS treatment. The company develops medications for the unmet needs of patients in the area of anti-HIV treatment and pain management.
TypePrivate
Founded2002
Websitefrontierbiotech.com

Latest Updates

Employees (est.) (Feb 2020)12
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Frontier Biotechnologies Financials and Metrics

Summary Metrics

Founding Date

2002

Frontier Biotechnologies total Funding

$43 m

Frontier Biotechnologies latest funding size

$43 m

Time since last funding

5 years ago

Frontier Biotechnologies investors

Frontier Biotechnologies's latest funding round in January 2017 was reported to be $43 m. In total, Frontier Biotechnologies has raised $43 m
Show all financial metrics

Frontier Biotechnologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Frontier Biotechnologies Online and Social Media Presence

Embed Graph

Frontier Biotechnologies News and Updates

AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

VIENNA, Austria, Dec. 22, 2021 (GLOBE NEWSWIRE) -- AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying Specific Active Immunotherapies (SAITs), today announced an exclusive collaboration and license agreement with Frontier Biotechnologies Inc. (688221.SH), a comme…

Frontier Biotechnologies Frequently Asked Questions

  • When was Frontier Biotechnologies founded?

    Frontier Biotechnologies was founded in 2002.

  • How many employees does Frontier Biotechnologies have?

    Frontier Biotechnologies has 12 employees.

  • Who are Frontier Biotechnologies competitors?

    Competitors of Frontier Biotechnologies include Macleods Pharmaceuticals, Sandoz and Alkem Laboratories.